Outset Medical Inc. (OM)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Outset Medical (OM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Outset Medical Q2 Earnings Call Highlights
Outset Medical NASDAQ: OM reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare.
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to a loss of $0.84 per share a year ago.
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
Outset Medical (OM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript
Outset Medical Q1 Earnings Call Highlights
Outset Medical NASDAQ: OM reported first-quarter 2026 revenue of $27.9 million, as management pointed to “consistent execution” in console utilization, new customer additions, gross margin expansion, and cash discipline, while acknowledging that capital order timing weighed on results.
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $3.24 per share a year ago.
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of Outset Medical, Inc. (NASDAQ: OM - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five research firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, two have given a buy
Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript
Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript
OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System
Outset Medical stock jumps after FDA clears next-gen Tablo dialysis system, the first to meet the agency's latest cybersecurity standards.
Outset Medical, Inc. (OM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Outset Medical, Inc. (OM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
